Upregulated stromal EGFR and vascular remodeling in mouse xenograft models of angiogenesis inhibitor-resistant human lung adenocarcinoma

Autor: CASCONE T, HERYNK MH, XU L, DU Z, KADARA H, NILSSON MB, OBORN CJ, PARK YY, EREZ B, JACOBY JJ, LEE JS, LIN HY, HERBST RS, LANGLEY RR, HEYMACH JV, CIARDIELLO, Fortunato

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3977::ef3502737f81a2422d4da1ee775eaf13
http://hdl.handle.net/11591/181901

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Porous silicon nanocarriers for dual targeting tumor associated endothelial cells and macrophages in stroma of orthotopic human pancreatic cancers.

Autor: Yokoi K; Department of Nanomedicine, The Methodist Hospital Research Institute, 6670 Bertner St., Houston, TX 77030, USA. KYokoi2@tmhs.org, Godin B, Oborn CJ, Alexander JF, Liu X, Fidler IJ, Ferrari M

Publikováno v: Cancer letters [Cancer Lett] 2013 Jul 01; Vol. 334 (2), pp. 319-27. Date of Electronic Publication: 2012 Sep 18.

Neoadjuvant platelet derived growth factor receptor inhibitor therapy combined with docetaxel and androgen ablation for high risk localized prostate cancer.

Autor: Mathew P; Department of Genitourinary Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA. pmathew@mdanderson.org, Pisters LL, Wood CG, Papadopoulos JN, Williams DL, Thall PF, Wen S, Horne E, Oborn CJ, Langley R, Fidler IJ, Pettaway CA

Publikováno v: The Journal of urology [J Urol] 2009 Jan; Vol. 181 (1), pp. 81-7; discussion 87. Date of Electronic Publication: 2008 Nov 13.

Mitochondrial inclusions in selenium-treated mouse mammary epithelial cell lines.

Autor: Medina D, Miller F, Oborn CJ, Asch BB

Publikováno v: Cancer research [Cancer Res] 1983 May; Vol. 43 (5), pp. 2100-5.